13F

Stock

Relmada Therapeutics, Inc.

RLMD · held by 2 managers

Reported value

$60.8K

Holders

2

+1 new · −0 exited

Holders’ est. mark

Need a prior quarter

Largest holder

$32.9K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC9.43K$32.9KHeld
Leonteq Securities AG8K$27.9KNew

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.